Good morning to all, I am looking forward to th

Good morning to all,

I am looking forward to the Investors Conference Call on Tuesday. It is very important for many reasons (and will affect the SP more that any other, imo) as, understandably many are feeling uneasy looking at the floor, so to speak, approaching rapidly.

What do I expect from the meeting ?

1) A clear explanation as of why the commercialization deal was not signed: was it them?, us? and if so, why ??? Is the Oncology explanation that NP provided related to pricing issues?
2) Results of 700mg safety data.
3) Has FDA communicated the dosage they want the BLA for ?? If not, when is it expected (any talks with FDA regarding this)??
4) How ready are we to submit BLA once this happens?
5) Any NASH developments in regards to BP "seeing the data ?"
6) What is the road ahead as far as finances go (in light of no commercialization deal signed).

I am always grateful to have these as, one way or another, provide information that helps us in making decisions but now, once our appetite was wetted by the potencial deal we are all hungry and without the cookie in sight.

Lets hope there are good news mostly in the Oncology space and the road is taking us to promised lands.